Xin Du

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Multiple Myeloma

Top Venues

British journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular pharmaceutics

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Cui, Xiaoyun Li, Shuhui Deng, Chenxing Du, Huishou Fan, Wenqiang Yan, Jingyu Xu, Xiaoqing Li, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Xiaojing Wei, Xin Du, Lian Xu, Shuhua Yi, Dehui Zou, Tao Cheng, Lugui Qiu, Xin Gao, Gang An
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Miao Li, Chang-Lin Zhang, Di-Sheng Zhou, Sze-Hoi Chan, Xue-Qi Liu, Shu-Na Chen, Zi-Yi Yang, Fei-Er Ju, Xiao-Yan Sang, Zi-Xuan Liu, Qiao-Xia Zhang, Yu-Ming Pan, Si-Si Deng, Xiao-Mei Wang, Li Zhong, Xing-Ding Zhang, Xin Du
Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells. British journal of haematology 204 (4) (2024)
Miao Li, Chang-Lin Zhang, Di-Sheng Zhou, Sze-Hoi Chan, Xue-Qi Liu, Shu-Na Chen, Zi-Yi Yang, Fei-Er Ju, Xiao-Yan Sang, Zi-Xuan Liu, Qiao-Xia Zhang, Yu-Ming Pan, Si-Si Deng, Xiao-Mei Wang, Li Zhong, Xing-Ding Zhang, Xin Du
Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells. British journal of haematology 204 (4) (2024)
Miao Li, Chang-Lin Zhang, Di-Sheng Zhou, Sze-Hoi Chan, Xue-Qi Liu, Shu-Na Chen, Zi-Yi Yang, Fei-Er Ju, Xiao-Yan Sang, Zi-Xuan Liu, Qiao-Xia Zhang, Yu-Ming Pan, Si-Si Deng, Xiao-Mei Wang, Li Zhong, Xing-Ding Zhang, Xin Du
Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells. British journal of haematology 204 (4) (2024)
Miao Li, Chang-Lin Zhang, Di-Sheng Zhou, Sze-Hoi Chan, Xue-Qi Liu, Shu-Na Chen, Zi-Yi Yang, Fei-Er Ju, Xiao-Yan Sang, Zi-Xuan Liu, Qiao-Xia Zhang, Yu-Ming Pan, Si-Si Deng, Xiao-Mei Wang, Li Zhong, Xing-Ding Zhang, Xin Du
Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells. British journal of haematology (2024)
Jian Cui, Xiaoyun Li, Shuhui Deng, Chenxing Du, Huishou Fan, Wenqiang Yan, Jingyu Xu, Xiaoqing Li, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Xiaojing Wei, Xin Du, Lian Xu, Shuhua Yi, Dehui Zou, Tao Cheng, Lugui Qiu, Xin Gao, Gang An
Identification of therapy-induced clonal evolution and resistance pathways in minimal residual clones in multiple myeloma through single-cell sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sisi Deng, Yuming Pan, Na An, Fengyi Chen, Huan Chen, Heng Wang, Xiaojing Xu, Rui Liu, Linlin Yang, Xiaomei Wang, Xin Du, Qiaoxia Zhang
Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells. Molecular oncology (2023)
Na An, Yuming Pan, Linlin Yang, Qiongli Zhang, Sisi Deng, Qiaoxia Zhang, Xin Du
Anti-Acute Myeloid Leukemia Activity of CD38-CAR-T Cells with PI3Kδ Downregulation. Molecular pharmaceutics (2023)
Na An, Yun Nan Hou, Qiao Xia Zhang, Ting Li, Qiong Li Zhang, Cheng Fang, Huan Chen, Hon Cheung Lee, Yong Juan Zhao, Xin Du
Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells. Molecular pharmaceutics 15 (10) (2018)